Do you or someone you care about have MS? MS PathwaysSM is the source for personalized support and timely information for BETASERON patients and those considering BETASERON therapy. To help you make the most of living with MS take advantage of the many helpful tools offered by MS PathwaysSM.
Get a printable doctor-patient discussion guide to help prepare you for speaking with your healthcare professional about choosing a disease-modifying therapy.
My MS My Way—Using technology to help improve the way you live with MS
In addition to providing the many benefits of MS PathwaysSM to people taking BETASERON, Bayer HealthCare Pharmaceuticals Inc., the distributor of BETASERON, has joined with other organizations that are passionate about helping those with MS maximize their abilities. This means you can reach out to help and be helped by others with MS through the online community.
At mymsmyway.com you can learn how existing technology can be adapted and used to meet your varying and unpredictable needs. Technology can also expand your social circle and help improve the way you manage your MS.
The MS Technology Collaborative
My MS My Way was developed by the MS Technology Collaborative, a landmark alliance of organizations passionate about helping people with MS maximize their abilities. The alliance brings together leaders from the pharmaceutical, technology, and patient advocacy sectors, including Bayer HealthCare Pharmaceuticals; Microsoft's Accessible Technology Group (ATG); and the National Multiple Sclerosis Society. Each organization has a specialized understanding of the needs of people with MS.
No matter what your specific challenges are, you can help take greater control of your life and health by visiting mymsmyway.com
BETASERON® (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Important Safety Information
The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.
